
As experimental drugs continue to fail in Alzheimer’s patients, research interest has increasingly shifted to finding a way to stop the disease long before it erodes people’s cognitive abilities.
But how do you identify the right people to target?
As experimental drugs continue to fail in Alzheimer’s patients, research interest has increasingly shifted to finding a way to stop the disease long before it erodes people’s cognitive abilities.
But how do you identify the right people to target?
advertisement